Pharmacological Risk Modification for Progression into Symptomatic Dementia: Complete Enumeration Study Utilizing Administrative Claims Record in Kashiwa City

Pharmacological Risk Modification for Progression into Symptomatic Dementia: Complete Enumeration Study Utilizing Administrative Claims Record in Kashiwa City - Pharmacological Risk Modification for Progression into Symptomatic Dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039040

Enrollment

42000

Registered

2020-01-01

Start date

2019-08-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer diseases Levy body dementia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All residents in Kashiwa city who are equal to or older than 77 years old at April 2012

Exclusion criteria

Exclusion criteria: 1. All residents in Kashiwa city who are equal to or younger than 76 years old at April 2012 2. All residents who had prescription of anti-dementia medication while between April and June 2012.

Design outcomes

Primary

Measure	Time frame
New prescription of anti-dementia medication	—

Countries

Japan

Contacts

Public ContactNobuhiro Handa

Pharmaceuticals and medical Devices Agency of Japan Medical Device Unit

handa-nobuhiro@pmda.go.jp03-3506-9447

Outcome results